17
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9223 | RO-0335 | Reverse Transcriptase | |
RO-0335 is a potent diphenylether nonnucleoside reverse transcriptase inhibitor. RO-0335 inhibits Wt HIV-1 (IC50 = 1.1 nM) and retained activity (IC50< 100 nM) against 92% of a large number of NNRTI-resistant clinical is... | |||
TQ0122L | VCH-916 free acid(1200133-34-1 free base) | HCV Protease | |
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor. | |||
T27260 | Emivirine | MKC442,MKC-442,MKC 442,DRG-0302,DRG 0302,DRG0302 | HIV Protease |
Emivirine (MKC-442) is a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1. | |||
T8800 | NSAH | 2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide | DNA/RNA Synthesis |
NSAH (2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide) is a nonnucleoside inhibitor of human ribonucleotide reductase (hRR).with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively... | |||
T12715 | Reverse transcriptase-IN-1 | HIV Protease | |
Reverse transcriptase-IN-1 is a diarylbenzopyrimidine (DABP) analogue and a potent inhibitor of HIV-1 nonnucleoside reverse transcriptase with an IC50of 13.7 nM. | |||
T30185 | AT 61 | AT61,AT-61 | |
AT-61 is a nonnucleoside analogue inhibitor of hepatitis B virus (HBV) replication. | |||
TQ0122 | VCH-916 | HCV Protease | |
VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase. | |||
T31085 | CP-94707 | UNII-YGC6408B5O | |
CP-94707 is a new inhibitor of nonnucleoside reverse transcriptase (NNRTI). | |||
T25363 | Efavirenz, (R)- | L 743725,L-743725,L743725 | |
Efavirenz, (R)- is an antiviral agent and a nonnucleoside HIV-1 reverse transcriptase inhibitor. | |||
T26442 | A 75925 | A-75925,A75925 | |
A 75925, a nonnucleoside reverse transcriptase inhibitors (NNRTI), works to inhibit HIV-1 replication. | |||
T27442 | GSK 224876 | GSK-224876,GSK224876 | |
GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects. | |||
T14086 | ABT-072 | Others | |
ABT-072 is a nonnucleoside NS5B polymerase inhibitor and a candidate drug evaluated for treatment of hepatitis C virus. | |||
T24794 | SJ-3366 | SJ 3366 | |
SJ3366 is a unique and highly potent nonnucleoside reverse transcriptase human immunodeficiency virus type 1 and HIV-2 inhibitor. | |||
T16081 | MIV-150 | PC 815 | Others |
MIV-150 is a nonnucleoside inhibitor of reverse transcriptase (NNRT). MIV-150 also blocking HIV-1 and HIV-2 infections (EC50<1 nM against HIV-1/HIV-2MN). | |||
T70212 | U 95133 | ||
U 95133 is a potent, broad-spectrum nonnucleoside reverse transcriptase inhibitor of drug-resistant isolates of human immunodeficiency virus type 1. | |||
T72283 | (+)-Dihydrocalanolide A | NSC 678323,DHCal A ; NSC 678323,DHCal A | |
(+)-Dihydrocalanolide A (DHCal A; NSC 678323), an orally active nonnucleoside inhibitor of reverse transcriptase, is utilized in research related to HIV infection. | |||
T78167 | PYR01 | ||
PYR01 is a potent nonnucleoside reverse transcriptase inhibitor of HIV-1 and concurrently acts as a targeted activator to eliminate cells expressing HIV-1 [1]. |